Investor Presentaiton

Investor Presentation First six months of 2018 Slide 73 Strong VictozaⓇ market leadership in Region Latin America Latin America GLP-1 market VictozaⓇ value market share in Latin America GLP-1 value in DKK VictozaⓇ exenatide dulaglutide Share of total other GLP-1 value billion diabetes care market market share VictozaⓇ exenatide dulaglutide other 100% 1 0.7 6% 0.6 CAGR value¹: 7.6% 5% 80% 0.5 -70% 4% 60% 0.4 3% 0.3 40% 2% 0.2 20% 1% 0.1 0.0 0% 0% May 2013 May 2018 May 2013 -28% 1% 0% May 2018 1 CAGR for 5-year period Source: IQVIA monthly MAT May, 2018 value figures (DKK) changing diabetes® Source: IQVIA monthly MAT May, 2018 value figures (DKK), market share does not add up to 100% due to rounding novo nordisk

View entire presentation